ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 85 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $477,000 | -42.7% | 361,736 | 0.0% | 0.01% | -50.0% |
Q3 2021 | $832,000 | +103.4% | 361,736 | +542.5% | 0.01% | +55.6% |
Q1 2021 | $409,000 | -87.1% | 56,297 | -92.3% | 0.01% | -89.3% |
Q4 2020 | $3,177,000 | +363.1% | 735,455 | +340.6% | 0.08% | +281.8% |
Q3 2020 | $686,000 | -60.9% | 166,909 | -42.9% | 0.02% | -68.1% |
Q2 2020 | $1,754,000 | -60.6% | 292,250 | -50.6% | 0.07% | -78.3% |
Q1 2020 | $4,452,000 | +187.2% | 591,250 | +424.4% | 0.32% | +404.8% |
Q4 2019 | $1,550,000 | – | 112,756 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |